Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38 -Lin-) in patients with myelodysplastic syndromes

Stem Cells

Volumn 23, Issue 5, 2005, Pages 619-630

  Ogata, Kiyoyuki ^a   Satoh, Chikako ^a   Tachibana, Mikiko ^a   Hyodo, Hideya ^a   Tamura, Hideto ^a   Dan, Kazuo ^a   Kimura, Takafumi ^b   Sonoda, Yoshiaki ^c   Tsuji, Takashi ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CD45; Hematopoietic stem cells; Myelodysplastic syndromes

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BONE MARROW; CANCER DIAGNOSIS; CELL ACTIVITY; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COLONY FORMING CELL; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMATURITY; IMMUNOPHENOTYPING; MALE; MALIGNANT TRANSFORMATION; MYELOBLAST; MYELODYSPLASTIC SYNDROME; PHENOTYPE; STROMA CELL;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MYELODYSPLASTIC SYNDROMES; MYELOID PROGENITOR CELLS;

EID: 18444373282     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0280     Document Type: Article

References (40)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
2. + adult stem cells during muscle regeneration. Cell 2003;113:841-852.
3. Civin CI, Almeida-Porada G, Lee MJ et al. Sustained, retransplantable, multilineage engraftment of highly purified adult hu man bone marrow stem cells in vivo. Blood 1996;88:4102-4109.
4. Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997;94:5320-5325.
5. Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998;4:1038-1045.
6. - cells assured by intra-bone marrow injection. Blood 2003;101:2924-2931.
7. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-369.
8. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649-1660.
9. + hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002;100:259-267.
10. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
11. Yoshida Y, Stephenson J, Mufti GJ. Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int J Hematol 1993;57:87-97.
12. Zipursky A, Bow E, Seshadri RS et al. Leukocyte density and volume in normal subjects and in patients with acute lymphoblastic leukemia. Blood 1976;48:361-371.
13. Ogata K. Usefulness of a novel Blastretriever for harvesting blasts. Nippon Rinsho 2001;59:2353-2357.
14. Hyodo H, Ogata K, Tachibana M et al. Characterization of blasts in clinical samples containing few blasts. Int J Hematol 2003;77:376-382.
15. Ogata K, Nakamura K, Yokose N et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002;100:3887-3896.
16. Ogata K, Satoh C, Hyodo H et al. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes. Leuk Res 2004;28:1171-1175.
17. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-625.
18. Mitelman F. ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger, 1995:1-114.
19. Ogata K, Yokose N, Shioi Y et al. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia. Br J Haematol 2001;115:612-615.
20. Borowitz MJ, Guenther KL, Shults KE et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993;100:534-540.
21. low/- cells generated in a xenogenic coculture system are capable of both long-term hematopoiesis and multiple differentiation. Leukemia 1999;13:1409-1419.
22. high+-primitive progenitor cells isolated from human umbilical cord blood in combination with human cytokines. Growth Factors 1999;16:225-240.
23. Ogata K. A simple centrifugation method for harvesting myeloblasts. Int J Hematol 2001;74:272-276.
24. Tsuji T, Ogasawara H, Aoki Y et al. Characterization of murine stromal cell clones established from bone marrow and spleen. Leukemia 1996;10:803-812.
25. - severe combined immunodeficiency repopulating cells that retain secondary reconstituting capacity. Int J Hematol 2004;79:328-333.
26. - cells in a long-term i n vitro system. Exp Hematol 2000;28:690-699.
27. Dan K, An E, Futaki M et al. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta Haematol 1993;89:113-118.
28. Nagler A, Ginzton N, Negrin R et al. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. Leukemia 1990;4:193-202.
29. Sato T, Kim S, Selleri C et al. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 1998;12:1187-1194.
30. Flores-Figueroa E, Gutierrez-Espindola G, Guerrero-Rivera S et al. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation. Leuk Res 1999;23:385-394.
31. Dick JE, Bhatia M, Gan O et al. Assay of human stem cells by repopulation of NOD/SCID mice. STEM CELLS 1997;15(suppl 1):199-203.
32. Benito AI, Bryant E, Loken MR et al. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk Res 2003;27:425-436.
33. Nilsson L, Astrand-Grundstrom I, Arvidsson I et al. Isolation and characterization of hematopoietic progenitor/stem cellsin 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 2000;96:2012-2021.
34. Liesveld JL, Jordan CT, Phillips GL II. The hematopoietic stem cell in myelodysplasia. STEM CELLS 2004;22:590-599.
35. Ema H, Suda T, Miura Y et al. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990;75:1941-1946.
36. + haematopoietic progenitor cells. Br J Haematol 1993;84:24-30.
37. Albitar M, Manshouri T, Shen Y et al. Myelodysplastic syndrome is not merely "preleukemia." Blood 2002;100:791-798.
38. Masuya M, Kita K, Shimizu N et al. Biologic characteristics of acute leukemia after myelodysplastic syndrome. Blood 1993;81:3388-3394.
39. Ogawa M. Changing phenotypes of hematopoietic stem cells. Exp Hematol 2002;30:3-6.
40. Messner H, Till JE, McCulloch EA. Density distributions of marrow cells from mouse and man. Ser Haematol 1972;5:22-36.